StratDeck

GRAIL

GRALHealthcare · Diagnostics & Research · US
99.25USDStratDeckSEC EDGARYahoo Finance

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.

1D−5.3%1W−14.4%1M−25.1%

Loading chart…

Checks

  • Locked: Price trend
  • Locked: Sales growth against its peers
  • Locked: Profit against similar companies
  • Locked: What analysts expect
  • Locked: Price against what it earns
  • Locked: Last quarter against forecasts

See how GRAIL does on each check. Sign in for two weeks free, with no card. Then StratDeck Pro is £5.99 a month or £60 a year.

Sign in